Symbol="JANX"
AssetType="Common Stock"
Name="Janux Therapeutics Inc"
Description="Janux Therapeutics, Inc., a biopharmaceutical company, develops therapies based on the patented Tumor Activated T Cell Engager (TRACTr) platform technology to treat cancer patients. The company is headquartered in La Jolla, California."
CIK="1817713"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="11099 TORREY PINES PARK ROAD, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="551844000"
EBITDA="-75741000"
PERatio="None"
PEGRatio="None"
BookValue="7.15"
DividendPerShare="0"
DividendYield="0"
EPS="-1.57"
RevenuePerShareTTM="0.186"
ProfitMargin="0"
OperatingMarginTTM="-9.96"
ReturnOnAssetsTTM="-0.133"
ReturnOnEquityTTM="-0.211"
RevenueTTM="7763000"
GrossProfitTTM="-44829000"
DilutedEPSTTM="-1.57"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.553"
AnalystTargetPrice="27.25"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="71.67"
PriceToBookRatio="1.697"
EVToRevenue="33.56"
EVToEBITDA="-4.025"
Beta="1.528"
num_52WeekHigh="23.64"
num_52WeekLow="10"
num_50DayMovingAverage="12.63"
num_200DayMovingAverage="14.56"
SharesOutstanding="45987000"
DividendDate="None"
ExDividendDate="None"
symbol="JANX"
open="11.93"
high="12.07"
low="11.16"
price="11.18"
volume="151240.00"
latest_trading_day="2023-08-16"
previous_close="12.00"
change="-0.82"
change_percent="-6.8333%"
aroon_positive_momentum_days="26"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="26"
Volume_recent_avg="122746"
Change_recent_avg="-0.02"
Delta_recent_avg="0.94"
Variance_recent_avg="0.47"
Change_ratio_recent_avg="-0.27"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_10"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="26"
Aroon_momentum_negative="74"
image_negative_thumbnail_id_1="136"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0040.jpeg"
image_negative_thumbnail_id_2="95"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0081.jpeg"
image_neutral_thumbnail_id_1="583"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_neutral_thumbnail_id_2="526"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_positive_thumbnail_id_1="981"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0143.jpeg"
image_positive_thumbnail_id_2="1011"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0173.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
